3//SEC Filing
Forbion Capital Fund II Cooperatief U.A. 3
Accession 0001104659-19-022010
CIK 0001760542other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 5:23 PM ET
Size
8.4 KB
Accession
0001104659-19-022010
Insider Transaction Report
Form 3
Holdings
- (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,146,118 underlying) - 9,314(indirect: See Footnote)
Common Stock
- (indirect: See Footnote)
Series C Preferred Stock
→ Common Stock (597,497 underlying) - (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (687,673 underlying)
Footnotes (2)
- [F1]The securities are held directly by Forbion Capital Fund II Cooperatief U.A ("Forbion Coop"). Forbion II Management B.V. ("Forbion Management") is the director of Forbion Coop and may be deemed to have voting, investment and dispositive power with respect to the shares held by Forbion Coop. Forbion Management disclaims Section 16 beneficial ownership of the shares held by Forbion Coop, except to the extent, if any, of its pecuniary interest therein.
- [F2]The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001767829
Filing Metadata
- Form type
- 3
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 5:23 PM ET
- Size
- 8.4 KB